Roche F. Hoffmann-La AG

Grenzacherstrasse 124
4070 Basel

Tel: +41 61 6881111


AI-powered solutions

Digital Pathology: Roche and PathAI team up

Roche announced that it has entered an agreement with PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology. Under the development and distribution agreement, the…


Image analysis integration

Roche opens access to digital pathology tools

Roche announced the introduction of the Roche Digital Pathology Open Environment that allows software developers to easily integrate their image analysis tools for tumour tissue with Roche’s uPath…


Antisense therapy update

Huntington's disease: setback for study of promising agent

Roche announced the decision to discontinue dosing in the Phase III GENERATION HD1 study of tominersen (previously IONIS-HTTRx and RG6042) in manifest Huntington’s disease (HD). The decision was…


Campaign to reprioritise breast health

Breast cancer: "Screening routine" to combat Covid-related backlog

One of the negative impacts of the coronavirus pandemic has been the suspension or postponement of many cancer screening services. Each year, these services help prevent and detect the presence of…


More targeted treatment

AI could improve outcomes for bowel cancer patients

A test which uses artificial intelligence (AI) to measure proteins present in some patients with advanced bowel cancer could hold the key to more targeted treatment, according to new research. A team…


Rapid antigen testing at point of care

AI-assisted SARS-CoV-2 testing: Cooperation for first live project in Munich

Medicus AI announces the successful launch of its first live project under SafePlay, the digital platform supporting rapid antigen testing, which went live in partnership with Roche Diagnostics…


Oncology and critical care treatment

GE and Roche partner up for integrated digital diagnostics platform

GE Healthcare has entered into a strategic, long-term partnership with Roche to jointly develop and co-market digital clinical decision support solutions. The partnership will initially focus on…


Sponsored • Automation

Proven Practices for Lab Automation Success

Cost constraints, higher workloads, and a shortage of qualified staff are three distinct market trends driving demand for greater efficiency in the laboratory. The goals of automation are to make…


Liquid biopsy test from Roche gets FDA approval

The U.S. Food and Drug Administration approved the cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved, blood-based…


Integration is key to tackling infectious diseases

World-renowned experts discussed the situation of predomonant epidemics at the International Roche Infectious Disease Symposium in Barcelona.


Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche

Samsung BioLogics today announced that Samsung BioLogics and F. Hoffmann-La Roche have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche's…


Faster sample analysis for UK and EU hospitals

Run by Sheffield Teaching Hospitals NHS Trust, the new automated Medical Laboratory at the Northern General Hospital has drawn a previously fragmented service into a purpose-built centre.


Barco and Ventana offer digital pathology imaging platform

Healthcare imaging expert Barco has signed a worldwide agreement with Ventana Medical Systems, Inc., a member of the Roche Group, to provide its leading diagnostic and clinical review display systems…


Connectivity and interoperability

Roche’s new information system aims to tackle the complexity and variability of clinical processes within and beyond laboratories.


Roche - on show and within reach

Roche Diagnostics showcased its full spectrum of cobas laboratory solutions at EuroMedLab this year. Visitors were given live demonstrations and shown videos of leading products for both small and…


Lab medicine is on the move, but where exactly is it going?

Facing the fundamental changes that laboratory medicine is undergoing, in early June Roche Diagnostics Deutschland GmbH invited 50 high-profile speakers to a six-day symposium to discuss current…


Cervical cancer

Data from the ATHENA (Addressing THE Need for Advanced HPV Diagnostics) USA registration trial, involving more than 47,000 women, demonstrate that two human papilloma virus genotypes, HPV 16 and HPV…



Effective screening can kill several birds with one stone

The MRSA problem has been ignored almost stoically in many European countries for the past 20 years. Thus the number of resistant Staphylococci cases exploded from 1% in 1990 around 25% in 2010.…

First on-site evaluation of the cobas 8000 clinical analyser

The Poole Hospital NHS Foundation Trust has become the first site, worldwide, to evaluate the full serum work area (SWA) capabilities of the cobas 8000 high throughput clinical analyser.


The value and development of PCR tests

Whereas, in the past, the diagnoses of infectious diseases focused on antibody detection, more recently laboratories aim to identify the agent itself, using the invaluable PCR (polymerase chain…


State-of-the-art diagnostic systems

Roche Diagnostics presents nine new products at this year’s Medica. Three of them were the focal point of today’s launch event at which customers and visitors had a chance to find out more about…


Roche and start initiative for early discovery of new diseases

Roche Applied Science and recently started a joint project to demonstrate the feasibility of developing a multidisciplinary surveillance, research and response system. This system will…


Hospital Universitari Vall d`Hebron to work with Roche technology

The Research Institute of the Hospital Universitari Vall d'Hebron (IR-HUVH) in Barcelona is the first Spanish health centre to acquire the Genome Sequencer FLX System from 454 Life Sciences, a Roche…


LightCycler MRSA Advanced Test cheats time

How the PCR-Test works

The MRSA bacterium contains an additional 'mobile gene cassette' (SCCmec cassette) in its genetic makeup, which contains the so-called mecA gene. All beta-Lactam…


Roche Launches Complete Detection Kit for Influenza A /H1N1

Roche Applied Science announced the availability of a new detection kit for the Influenza A/H1N1 virus. The detection kit is offered for use in life science research. Roche currently is filing to…


Genome Structural Variation Consortium used Roche technology

Roches NimbleGen´s CGH microarray platform was used to generate the highest-resolution map of human genome copy number variation. Recent advances in microarray technology have led to the discovery…


New insights of the role of microbial communities in the Human Gut

454 Life Sciences, a Roche company, announced that a team of researchers at Washington University in St. Louis have characterized the human gut microbiome by sequencing the microbial communities of…


Roche expands its portfolio of laboratory information systems

Roche and Swisslab GmbH, Berlin announced yesterday that Roche has acquired all the shares in Swisslab. Swisslab is the leading provider of Laboratory Information Systems (LIS) in Germany. The…


Roche launch the new BenchMark® ULTRA

With the acquisition of Ventara Medical Systems, Roche hopes to move several steps further forward in their goal for personalised medicine that improves diagnostics and ultimately, clinical outcomes.


Computer-assisted diabetes risk management

Optimal treatment of diabetes is very difficult to achieve since many obstacles have to be overcome such as expensive treatments, poor patient compliance or insufficient datac. With these challenges…


Arrays to detect genomic disorder

Roche reports that, using its NimbleGen CGH arrays, researchers* have identified a recurrent reciprocal genomic rearrangement of chromosomal region 17q12 in foetal samples with congenital anomalies…


Automated urinalysis systems

Roche's product portfolio includes three systems for urinary diagnostics, all of which use the proven Combur test strips.


Peter Loescher: The unknown famous manager

When the Siemens board of directors announced its decision for the new Siemens CEO on Sunday, the economic world was surprised: Not only that the name Peter Löscher was never mentioned in the…


Integration in 3 stages

Hospitals increasingly co-operate with other establishments, and networking is becoming a way of life. Such change is also occurring in many hospital laboratories. By co-operating with other hospital…


Pandemic panic sends feathers flying

AIDS, SARS and now H5NI; just a brief beginning or the end? As the virus moves towards Europe, and millions of birds are slaughtered, interest has risen in a Chinese herb, a patent-sharing…


Partnerships to personalise medicine

Peter Loescher has worked at the cutting edge of the pharmaceutical industry for 17 years. In the latter part of this period, for example, he headed Hoechst's division in Japan, where he was also…


Quick change lancets

Although taking a tiny blood sample for self-monitoring should be as easy as possible for the diabetic patient, this has not been an easy task because changing a used lancet has proved a fiddly and…


Web advisories aid physicians

Monitoring and rapidly introducing new developments into everyday practice is an increasingly difficult task for many doctors. Additionally, patients are more informed due to media medical reports,…

Subscribe to Newsletter